Medically reviewed by Oluseun Olufade, MD Key Takeaways Staying hydrated and getting enough electrolytes—including potassium, ...

Muscle loss was linked to higher dementia risk, while obesity showed different patterns depending on age at measurement.

A new study has identified the HDAC11 protein, an enzyme involved in cellular regulation, as a new potential therapeutic target for the treatment of sarcopenia. Sarcopenia, the progressive loss of ...

A team of Vanderbilt researchers has developed a wirelessly activated device that mimics the wavelike muscular function in the esophagus and small intestine responsible for transporting food and ...

Overall, these findings suggest that creatine supplementation may provide benefits beyond exercise performance and that ...

A study involving healthy adults between 45 and 65 years of age with a sedentary lifestyle found that 12 weeks of taking ...

Apitegromab is the first SMA therapy to directly target muscle loss and is approved as add-on treatment for patients aged 2 years and older receiving an SMN2-targeted therapy.

Researchers report that an experimental drug first developed to treat kidney disease prolongs survival and improves muscle function in mice genetically engineered to develop a severe form of Duchenne ...

New research has identified the enzyme glutamate dehydrogenase 1 (GLUD1) as a new therapeutic target for Duchenne muscular dystrophy (DMD). In preclinical DMD mouse models, investigators demonstrated ...

Physical therapy supports Duchenne muscular dystrophy (DMD) care by maintaining strength and flexibility, improving movement, and lowering the risk of contractures. A physical therapist also monitors ...

A team of researchers has developed a wirelessly activated device that mimics the wavelike muscular function in the esophagus and small intestine responsible for transporting food and viscous fluids ...